Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | AHCY | P23526 | 5/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13248702 | 1.00 | ATM (0.43) | ATMDOT1LALDH1A1AHCYADORA2A | |
| SCHEMBL14472999 | 0.77 | AHCY (0.60) | ALDH1A1AHCYADORA2A | |
| SCHEMBL10284145 | 0.77 | AHCY (0.60) | ALDH1A1AHCYADORA2A | |
| SCHEMBL13248701 | 0.76 | EGFR (0.55) | ALDH1A1AHCYADORA2A | |
| SCHEMBL13248700 | 0.74 | PI4KA (0.43) | AHCYADORA2A | |
| SCHEMBL14472890 | 0.74 | PI4KA (0.43) | AHCYADORA2A | |
| SCHEMBL14139510 | 0.74 | AHCY (0.56) | ALDH1A1AHCYADORA2A | |
| SCHEMBL14379019 | 0.72 | ADORA2A (0.60) | ALDH1A1AHCYADORA2A | |
| SCHEMBL91115 | 0.72 | CDK1 (0.55) | ADORA2A | |
| SCHEMBL2547442 | 0.71 | CYP3A4 (0.47) | ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155699-A1 | Boron-containing small molecules | ETF1, POLR1C, DPM1 | ATM 4841/4885DOT1L 1762/4885ALDH1A1 3692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.